Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript. The Company maintains a strong balance sheet with low gearing (debt-to-equity of 0.21) and a net worth of INR 5,550 crore, supporting planned expansion. CAPEX plans over the next three years amount to around INR 9,000 crore, with INR 3,000-4,000 crore expected to be spent annually, but funding sources are not detailed. The Company emphasizes prudent capital allocation and disciplined execution to support growth. No clear statements regarding raising fresh debt or issuing equity

Any current/future capex/capital investment/strategic investment?

Total capex over the next 3 years is around INR 9,000 crore. Planned capex breakdown: approximately INR 3,000-3,500 crore in FY26, and around INR 4,000 crore in FY27. Major investment is in the integrated polycarbonate project, targeting commissioning by March 2028. The project includes upstream products like Nitric Acid and downstream products like MIBK and MIBC to be operationalized in coming quarters. Investment includes acquisition of technology and assets for polycarbonate production (agreement signed with Trinseo). Appointed dismantling contractor and EPCM for polycarbonate project; grou

Future growth expectations in sales/revenue/volumes?

Cautious optimism about H2 FY26, expecting better performance than Q2 due to improving market and demand sentiment. (Page 18) Phenol volume growth was moderate (2-3%) in Q2; potential for increased output in H2 aided by cooler climate and operational efficiencies. (Page 9) Continuous debottlenecking efforts leading to volume growth beyond previous 10% capacity increase; further improvements targeted with low CAPEX. (Page 9) Advanced Intermediates segment expecting recovery and better trajectory in H2 FY26, with new products starting production and ramp-up towards Q4 FY26 and FY27. (Page 13) On

Future growth expectations in earnings/operating earnings/profits/EPS?

The company is cautiously optimistic about H2 FY26, expecting better demand and market sentiment compared to Q2. New product launches (7 in Q2) in Advanced Intermediates with good margin profiles are expected to significantly contribute to growth in FY27, especially in Q2 FY27. Ongoing commissioning of Nitric Acid, MIBK/MIBC, and specialty chemical plants will enhance competitiveness and margins. The integrated polycarbonate project commissioning is targeted for January-March 2028, expected to be a significant value driver. Cost control measures and fixed cost reductions are ongoing, supportin

IN US

Sale is live|00:00:00left today

Deepak Nitrite LtdQ3 FY25Chemicals & Petrochemicals

Deepak Nitrite Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,670P/E: 44.5Market Cap: ₹24.9K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Cautious optimism about H2 FY26, expecting better performance than Q2 due to improving market and demand sentiment. (Page 18)
→Phenol volume growth was moderate (2-3%) in Q2; potential for increased output in H2 aided by cooler climate and operational efficiencies. (Page 9)
→Continuous debottlenecking efforts leading to volume growth beyond previous 10% capacity increase; further improvements targeted with low CAPEX. (Page 9)
→Advanced Intermediates segment expecting recovery and better trajectory in H2 FY26, with new products starting production and ramp-up towards Q4 FY26 and FY27. (Page 13)
→Ongoing projects like Nitric Acid, MIBK/MIBC plants and specialty chemicals nearing commissioning, expected to improve competitiveness and growth. (Page 6)
→Polycarbonate project commissioning targeted by March 2028, expected to enhance revenue over coming years. (Page 15-18)

Margin guidance

Category 2

→The company is cautiously optimistic about H2 FY26, expecting better demand and market sentiment compared to Q2.
→New product launches (7 in Q2) in Advanced Intermediates with good margin profiles are expected to significantly contribute to growth in FY27, especially in Q2 FY27.
→Ongoing commissioning of Nitric Acid, MIBK/MIBC, and specialty chemical plants will enhance competitiveness and margins.
→The integrated polycarbonate project commissioning is targeted for January-March 2028, expected to be a significant value driver.
→Cost control measures and fixed cost reductions are ongoing, supporting margin expansion.
→Operating efficiencies, including phenol plant debottlenecking, will yield moderate volume growth.
→The company expects improved profitability driven by operational excellence, innovation, and strategic investments in sustainability and integration.
→ROCE reported at 14%, reflecting capital-efficient operations.
→Revenue growth in H1 FY26 was stable; improvement is anticipated in the second half and FY27 with ramp-up of new products and projects.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript.
→The Company maintains a strong balance sheet with low gearing (debt-to-equity of 0.21) and a net worth of INR 5,550 crore, supporting planned expansion.
→CAPEX plans over the next three years amount to around INR 9,000 crore, with INR 3,000-4,000 crore expected to be spent annually, but funding sources are not detailed.
→The Company emphasizes prudent capital allocation and disciplined execution to support growth.
→No clear statements regarding raising fresh debt or issuing equity were made during the call.

Order book

The transcript does not explicitly mention details about the current or expected order book or pending orders for Deepak Nitrite Limited. However, indirect insights can be noted: - Multiple agreements have been signed for licensing and technology for the phenol plant and polycarbonate resin production. - Advanced stages of discussions are ongoing for integrating certain utilities within the asset. - Dismantling and EPCM appointments for the polycarbonate project are underway, indicating active project execution. - Positive engagements with strategic partners in agrochemical intermediates and other specialty chemical areas hint at future order flows and collaborations. - The company mentions ongoing projects and new product launches, suggesting a healthy project pipeline. - Cautious optimism on improving demand in H2 FY26 implies potential for new orders or order recoveries. No quantifiable data on order book size or pending orders is provided.

Capex plans

Yes

→Total capex over the next 3 years is around INR 9,000 crore.
→Planned capex breakdown: approximately INR 3,000-3,500 crore in FY26, and around INR 4,000 crore in FY27.
→Major investment is in the integrated polycarbonate project, targeting commissioning by March 2028.
→The project includes upstream products like Nitric Acid and downstream products like MIBK and MIBC to be operationalized in coming quarters.
→Investment includes acquisition of technology and assets for polycarbonate production (agreement signed with Trinseo).
→Appointed dismantling contractor and EPCM for polycarbonate project; groundwork and site development already started.
→Strategic discussions ongoing for utilities supply and optimization in integrated assets.
→Investment also in enhancing R&D capabilities with a state-of-the-art center focused on new molecule development and process intensification.
→Cost control measures are ongoing to improve fixed costs alongside capital investments.

How does Deepak Nitrite Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Deepak Nitrite Ltd

Rev 3Mar 2

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Deepak Nitrite Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio